Safety and patient-reported outcomes associated with abatacept in the treatment of rheumatoid arthritis patients who received background disease modifying anti-rheumatic drugs (DMARDS): The ASSURE trial

Authors
Category Primary study
Conference69th Annual Scientific Session of the American College of Rheumatology; San Diego, Calif
Year 2005
This article has no abstract
Epistemonikos ID: a800c65645be57bfdc23177e5eecc3c9579a67dd
First added on: Jun 01, 2019